517 related articles for article (PubMed ID: 6319426)
21. Novel vitamin D3 derivatives, 26-homo-delta 22-dehydro-1 alpha,25(S)-dihydroxyvitamin D3 and 26-homo-delta 22-dehydro-1 alpha,25(R)-dihydroxyvitamin D3: preferential activity in c-myc mRNA production and in induction of phenotypic differentiation of HL-60 cells.
Koizumi T; Nakao Y; Ishizuka S; Oshida J; Hara N; Ikekawa N; Fijita T
Arch Biochem Biophys; 1990 Feb; 276(2):310-6. PubMed ID: 2407190
[TBL] [Abstract][Full Text] [Related]
22. 1,25-Dihydroxyvitamin D3 and phorbol myristate acetate produce divergent phenotypes in a monomyelocytic cell line.
Biskobing DM; Rubin J
Endocrinology; 1993 Feb; 132(2):862-6. PubMed ID: 8425498
[TBL] [Abstract][Full Text] [Related]
23. Promotion of HL-60 cell differentiation by 1,25-dihydroxyvitamin D3 regulation of protein kinase C levels and activity.
Pan Q; Granger J; O'Connell TD; Somerman MJ; Simpson RU
Biochem Pharmacol; 1997 Oct; 54(8):909-15. PubMed ID: 9354591
[TBL] [Abstract][Full Text] [Related]
24. Effects of calmodulin antagonists and cytochalasins on proliferation and differentiation of human promyelocytic leukemia cell line HL-60.
Matsui T; Nakao Y; Kobayashi N; Koizumi T; Nakagawa T; Kishihara M; Fujita T
Cancer Res; 1985 Jan; 45(1):311-6. PubMed ID: 3855282
[TBL] [Abstract][Full Text] [Related]
25. Functional defect of variant clones of a human myeloid leukemia cell line (HL-60) resistant to 1 alpha,25-dihydroxyvitamin D3.
Kuribayashi T; Tanaka H; Abe E; Suda T
Endocrinology; 1983 Dec; 113(6):1992-8. PubMed ID: 6315339
[TBL] [Abstract][Full Text] [Related]
26. Influence of 1,25-dihydroxyvitamin D3 on cultured osteogenic sarcoma cells: correlation with the 1,25-dihydroxyvitamin D3 receptor.
Dokoh S; Donaldson CA; Haussler MR
Cancer Res; 1984 May; 44(5):2103-9. PubMed ID: 6324995
[TBL] [Abstract][Full Text] [Related]
27. 1,25(OH)2-vitamin D3 mediated changes in mRNA for c-myc and 1,25(OH)2D3 receptor in HL-60 cells and related subclones.
Taoka T; Collins ED; Irino S; Norman AW
Mol Cell Endocrinol; 1993 Sep; 95(1-2):51-7. PubMed ID: 8243807
[TBL] [Abstract][Full Text] [Related]
28. The involvement of calcium ions in the effect of 1,25-dihydroxyvitamin D3 on HL-60 cells.
Levy R; Nathan I; Barnea E; Chaimovitz C; Shany S
Exp Hematol; 1988 May; 16(4):290-4. PubMed ID: 3129299
[TBL] [Abstract][Full Text] [Related]
29. 1,25(OH)2-16ene-vitamin D3 is a potent antileukemic agent with low potential to cause hypercalcemia.
Jung SJ; Lee YY; Pakkala S; de Vos S; Elstner E; Norman AW; Green J; Uskokovic M; Koeffler HP
Leuk Res; 1994 Jun; 18(6):453-63. PubMed ID: 8207963
[TBL] [Abstract][Full Text] [Related]
30. Monocytic differentiation of acute promyelocytic leukemia cells in response to 1,25-dihydroxyvitamin D3 is independent of nuclear receptor binding.
Bhatia M; Kirkland JB; Meckling-Gill KA
J Biol Chem; 1995 Jul; 270(27):15962-5. PubMed ID: 7608152
[TBL] [Abstract][Full Text] [Related]
31. 1,25-Dihydroxyvitamin D3 receptor RNA: expression in hematopoietic cells.
Kizaki M; Norman AW; Bishop JE; Lin CW; Karmakar A; Koeffler HP
Blood; 1991 Mar; 77(6):1238-47. PubMed ID: 1705836
[TBL] [Abstract][Full Text] [Related]
32. Effect of hexafluoro-1,25-dihydroxyvitamin D3 and sodium butyrate combination on differentiation and proliferation of HL-60 leukemia cells.
Yoshida M; Tanaka Y; Eguchi T; Ikekawa N; Saijo N
Anticancer Res; 1992; 12(6B):1947-52. PubMed ID: 1363510
[TBL] [Abstract][Full Text] [Related]
33. Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues.
Koeffler HP; Amatruda T; Ikekawa N; Kobayashi Y; DeLuca HF
Cancer Res; 1984 Dec; 44(12 Pt 1):5624-8. PubMed ID: 6594194
[TBL] [Abstract][Full Text] [Related]
34. Vitamin D3 analogs: effect on leukemic clonal growth and differentiation, and on serum calcium levels.
Pakkala S; de Vos S; Elstner E; Rude RK; Uskokovic M; Binderup L; Koeffler HP
Leuk Res; 1995 Jan; 19(1):65-72. PubMed ID: 7837819
[TBL] [Abstract][Full Text] [Related]
35. Enhancement by dimethyl sulfoxide of 1,25-dihydroxyvitamin D3-induced differentiation in human promyelocytic HL-60 leukemia cells requires dimethyl sulfoxide-induced G0/G1 arrest.
Odani T; Kohroki J; Nakanishi T; Itoh N; Muto N; Tanaka K
Res Commun Mol Pathol Pharmacol; 2000; 108(5-6):381-91. PubMed ID: 11958291
[TBL] [Abstract][Full Text] [Related]
36. Capsaicin potentiates 1,25-dihydoxyvitamin D3- and all-trans retinoic acid-induced differentiation of human promyelocytic leukemia HL-60 cells.
Kang SN; Chung SW; Kim TS
Eur J Pharmacol; 2001 May; 420(2-3):83-90. PubMed ID: 11408028
[TBL] [Abstract][Full Text] [Related]
37. Potentiation by 1-alpha,25-dihydroxyvitamin D3 of cytotoxicity to HL-60 cells produced by cytarabine and hydroxyurea.
Studzinski GP; Bhandal AK; Brelvi ZS
J Natl Cancer Inst; 1986 Apr; 76(4):641-8. PubMed ID: 3457201
[TBL] [Abstract][Full Text] [Related]
38. Differentiated HL-60 promyelocytic leukaemia cells produce a factor inducing differentiation.
Djulbegović B; Christmas SE; Moore M
Leuk Res; 1987; 11(3):259-64. PubMed ID: 3470575
[TBL] [Abstract][Full Text] [Related]
39. 25-Hydroxyvitamin D3 metabolism in a human leukemia cell line.
Bar-Shavit Z; Horst RL; Chappel JC; Ross FP; Gray RW; Teitelbaum SL
Calcif Tissue Int; 1986 Nov; 39(5):328-33. PubMed ID: 3102023
[TBL] [Abstract][Full Text] [Related]
40. 1 alpha,25-Dihydroxy-20-epi-vitamin D3: an extraordinarily potent inhibitor of leukemic cell growth in vitro.
Elstner E; Lee YY; Hashiya M; Pakkala S; Binderup L; Norman AW; Okamura WH; Koeffler HP
Blood; 1994 Sep; 84(6):1960-7. PubMed ID: 8080998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
